Stock-Based Compensation for Elevance Health (ELV)
Stock-Based Compensation for Elevance Health (ELV): headline value $250.00M · YoY +44.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingStock-Based CompensationSwitch metric
Latest period
$250.00M
YoY change
+44.5%
5Y CAGR
-0.5%
Peak year (2019)
$294.00M
Latest annual
$276.00M
Stock-Based Compensation history chart for Elevance Health (ELV) from 2001 to 2025
Stock-Based Compensation history table for Elevance Health (ELV) from 2001 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $276.00M | +44.5% | ||
| 2024 | $191.00M | -33.9% | ||
| 2023 | $289.00M | +9.5% | ||
| 2022 | $264.00M | +3.5% | ||
| 2021 | $255.00M | -9.9% | ||
| 2020 | $283.00M | -3.7% | ||
| 2019 | $294.00M | +30.1% | ||
| 2018 | $226.00M | +33.3% | ||
| 2017 | $169.60M | +3.0% | ||
| 2016 | $164.60M | +11.1% | ||
| 2015 | $148.20M | -12.3% | ||
| 2014 | $168.90M | +15.7% | ||
| 2013 | $146.00M | -0.3% | ||
| 2012 | $146.50M | +8.7% | ||
| 2011 | $134.80M | -0.9% | ||
| 2010 | $136.00M | -11.5% | ||
| 2009 | $153.60M | -1.5% | ||
| 2008 | $156.00M | -11.9% | ||
| 2007 | $177.10M | -28.3% | ||
| 2006 | $246.90M | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — |
Stock-Based Compensation values are taken from Elevance Health's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Elevance Health (ELV) stock-based compensation totalled $276.00M – surged 44.5% year-over-year.
Over 2020–2025 (5 years), Elevance Health stock-based compensation expanded at a -0.5% compound annual rate, with a net decline across the window.
The dataset's maximum stock-based compensation sits at $294.00M (2019); the minimum reading of $0 dates to 2001.
Within Healthcare, Elevance Health (ELV) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
Elevance Health Stock-Based Compensation by Year
Elevance Health Stock-Based Compensation 2025: $276.00M
Elevance Health stock-based compensation in 2025 was $276.00M, surged 44.5% from 2024.
Elevance Health Stock-Based Compensation 2024: $191.00M
Elevance Health stock-based compensation in 2024 was $191.00M, plunged 33.9% below 2023.
Elevance Health Stock-Based Compensation 2023: $289.00M
Elevance Health stock-based compensation in 2023 was $289.00M, grew 9.5% from 2022.
Elevance Health Stock-Based Compensation 2022: $264.00M
Elevance Health stock-based compensation in 2022 was $264.00M, edged up 3.5% from 2021.
Elevance Health Stock-Based Compensation 2021: $255.00M
Elevance Health stock-based compensation in 2021 was $255.00M.
See more financial history for Elevance Health (ELV).
Sector peers — Stock-Based Compensation
Companies in the same sector as Elevance Health, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Elevance Health's stock-based compensation?
Latest reported stock-based compensation for Elevance Health (ELV) is $250.00M (period ending March 31, 2026).
How has Elevance Health stock-based compensation changed year-over-year?
Elevance Health (ELV) stock-based compensation changed +44.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Elevance Health stock-based compensation?
Elevance Health (ELV) stock-based compensation compound annual growth rate is -0.5% over the most recent 5 years available.
When did Elevance Health stock-based compensation hit its highest annual value?
Elevance Health stock-based compensation reached its highest annual value of $294.00M in 2019.
What was Elevance Health stock-based compensation in 2024?
Elevance Health (ELV) stock-based compensation in 2024 was $191.00M.
What was Elevance Health stock-based compensation in 2025?
Elevance Health (ELV) stock-based compensation in 2025 was $276.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ELV Overview
Company profile, financial tools, and key metrics
ELV Revenue Counter
Earns $6,355 every second. See per minute, hour, and day.
ELV Earnings Counter
Earns $166.25 per second net profit. See per minute, hour, and day.
ELV Economic Scale
Exceeds Ukraine's GDP. Compare with world economies.
ELV What If Invested
What if you had invested $1,000? See historical returns from any date.
ELV How It Makes Money
Discover visual breakdown of $200.41B in revenue — where it comes from and where it goes.
ELV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ELV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ELV Daily Price Character
Steady · 51.8% historical win rate (green days). Streaks & record days.
ELV Buybacks
4.41% TTM buyback yield. Shareholder yield & SBC comparison.
ELV Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
ELV Dividend Profile
Yield: 1.82%. Safety: 7/8. See full history.
ELV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ELV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.